Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of the multicenter, randomized, open-label, controlled phase II study is to determine whether pegylated recombinant human growth hormone is effective in the treatment of children with growth hormone deficiency.
Epistemonikos ID: 42a3bb1501592848665b85a29e608f342441aa5d
First added on: May 06, 2024